Influence of clinical and demographic variables on quality of life in patients with Parkinson's disease

Journal of Neurology Neurosurgery and Psychiatry

Volumn 66, Issue 4, 1999, Pages 431-435

  Karlsen, Karen Herlofson ^a   Larsen, Jan P ^a   Tandberg, Elise ^a   Mæland, John G ^b  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

Multiple regression analysis; Parkinson's disease; Quality of life

Indexed keywords

AGED; ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DISTRESS SYNDROME; ENERGY; FEMALE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; NORWAY; PARKINSON DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; SCORING SYSTEM; SLEEP DISORDER;

EID: 0033043256     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.66.4.431     Document Type: Article

References (29)

1. Shindler J, Brown R, Welburn P, et al. Measuring the quality of life of patients with Parkinson's disease. In: Walker S, Rosser R, eds. Quality of life: assessment and applications. Lancaster: MTP Press, 1988.
2. Welburn P, Walker S. Assessment of quality of life in Parkinson's disease. In: Teeling Smith G, ed. Measuring health: a practical approach. Chichester, Wiley, 1988.
3. Mutch WJ, Strudwick A, Roy SK, et al. Parkinson's disease: disability, review, and management. BMJ 1986;239:675-7.
4. Jenkinson C, Peto V, Fitzpatrick R, et al. Self-reported functioning and well-being in patients with Parkinson's disease: comparison of the short-form health survey (SF-36) and the Parkinson's disease questionnaire (PDQ-39). Age Ageing 1995;24:505-9.
5. Jenkinson C, Fitzpatrick R, Argyle M. The Nottingham health profile: an analysis of its sensitivity in differentiating illness groups. Soc Sci Med 1988;27:1411-4.
6. Bergner M, Bobbitt RA, Carter WB, et al. The sickness impact profile: development and final revision of a health status measure. Med Care 1981;19:787-805.
7. Peto V, Jenkinson C, Fitzpatrick R, et al. The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease. Qual Life Res 1995;4:241-8.
8. de Boer AGEM, Wijker W, Speelman JD, et al. Quality of life in patients with Parkinson's disease: development of a questionnaire. J Neurol Neurosurg Psychiatry 1996;61:70-4.
9. Longstreth WT Jr, Nelson L, Linde M, et al. Utility of the sickness impact profile in Parkinson' disease. J Geriatr Psychiatry Neurol 1992;5:142-8.
10. Block G, Liss C, Reines S, et al. Comparison of immediate-release and controlled release carbidopa/levodopa in Parkinson's disease. Eur Neurol 1997;37:23-7.
11. Hunt SM, McKenna SP, McEwen J, et al. The Nottingham health profile: subjective health status and medical consultations. Soc Sci Med 1981;15A:221-9.
12. Hunt SM, McEwen J, McKenna SP. Measuring health status: a new tool for clinicians and epidemiologists. J Coll Gen Pract 1985;35:185-88.
13. Hunt SM, McEwen J, McKenna SP. Measuring health status. London: Croom Helm, 1986.
14. Tandberg E, Larsen JP, Nessler EG, et al. The epidemiology of Parkinson's disease in the county of Rogaland, Norway. Mov Disord 1995;10:541-9.
15. Larsen JP, Dupont E, Tandberg E. The clinical diagnosis of Parkinson's disease: proposal of diagnostic subgroups classified at different levels of confidence. Acta Neurol Scand 1994;84:242-51.
16. Fahn S, Elton RL and members of the UPDRS Development Committee. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne DB, et al, eds. Recent developments in Parkinson's disease. Florham Park, NJ: MacMillan Health Care Information, 1987:153-63.
17. Hoehn M, Yahr M. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-42.
18. Schwab RS, England AC. Projection technique for evaluating surgery in Parkinson's disease. In: Gillingham FJ, Donaldson IML, eds. Third symposium on Parkinson's disease. Edinburgh: E and S Livingstone, 1969.
19. Folstein MF, Folstein SE, McHugh PR. Mini-mental state: a practical method for grading the mental state of patients for the clinicians. J Psychiatr Res 1975;12:189-98.
20. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington, DC: APA, 1987.
21. Montgomery SA, Åsberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:322-89.
22. Dornan TL, Peck GM, Dow JDC, et al. A community survey of diabetes in the elderly. Diabet Med 1992;9:860-5.
23. Essink-Bot ML, van Royen L, Krabbe P, et al. The impact of migraine on health status. Headache 1995;35:200-6.
24. Tandberg E, Larsen JP, Aarsland D, et al. The occurrence of depression in Parkinson's disease: a community-based study. Arch Neurol 1996;53:175-9.
25. Cummings JL. Depression and Parkinsons' disease: a review. Am J Psychiatry 1992;149:443-54.
26. Lees AJ, Blackburn NA, Campell VL. The nighttime problems of Parkinson's disease. Clin Neuropharmacol 1988;6: 512-9.
27. Nausieda PA, Weiner WJ, Kaplan LR, et al. Sleep disruption in the chronic levodopa therapy: an early feature of the levodopa psychosis. Clin Neuropharmacol 1982;2:183-94.
28. Hendersen L, Kennard C, Crawford T. Scales for rating motor impairment in Parkinson's disease: studies of reliability and convergent validity. J Neurol Neurosurg Psychiatry 1991;54:18-24.
29. Friedman J, Friedman H. Fatigue in Parkinson's disease. Neurology 1993;43:2016-8.